About GC Aesthetics
GC Aesthetics is a company based in Dublin (Ireland) founded in 2007. It operates as a Direct-to-Consumer (D2C) and Professional Services. GC Aesthetics has raised $232.81 million across 8 funding rounds from investors including Hayfin, Orbimed and Montreux Equity Partners. GC Aesthetics offers products and services including GCA Breast Implants, Nagor Implants, and GCA Comfort Plus Warranty. GC Aesthetics operates in a competitive market with competitors including Sientra, Establishment Labs, AirXpanders, BioAesthetics and Novasys Medical, among others.
- Headquarter Dublin, Ireland
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gc Aesthetics®
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$232.81 M (USD)
in 8 rounds
-
Latest Funding Round
$97 M (USD), Series E
Oct 29, 2018
-
Investors
Hayfin
& 16 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GC Aesthetics
GC Aesthetics offers a comprehensive portfolio of products and services, including GCA Breast Implants, Nagor Implants, and GCA Comfort Plus Warranty.
Breast implants are provided for aesthetic enhancement purposes.
Nagor implants are offered for natural breast augmentation.
Warranty services are extended for breast implant patients.
People of GC Aesthetics
Unlock access to complete
Funding Insights of GC Aesthetics
GC Aesthetics has successfully raised a total of $232.81M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $97 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GC Aesthetics
GC Aesthetics has secured backing from 17 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Hayfin, Orbimed and Montreux Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private debt investments are directed across multiple sectors.
|
Locked | Locked | Locked | |
|
Growth capital investments are made in healthcare and fintech companies.
|
Locked | Locked | Locked | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked |
Investor details for GC Aesthetics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GC Aesthetics
Investment portfolio details for GC Aesthetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GC Aesthetics
Detailed financials for GC Aesthetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gc Aesthetics Comparisons
Peer comparison for GC Aesthetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GC Aesthetics
GC Aesthetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sientra, Establishment Labs, AirXpanders, BioAesthetics and Novasys Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Products for plastic surgery and aesthetics are developed and marketed.
|
|
| Locked | Locked | Locked |
Silicone-filled breast and body shaping implants are designed and manufactured.
|
|
| Locked | Locked | Locked |
Tissue expansion technology for breast reconstruction surgery is developed.
|
|
| Locked | Locked | Locked |
Tissue-engineered nipple-areolar complexes are developed for post-mastectomy use.
|
|
| Locked | Locked | Locked |
Therapeutics for female pelvic disorders, including SUI treatments, were developed.
|
Detailed competitors of GC Aesthetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gc Aesthetics
Complete news archive for GC Aesthetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GC Aesthetics
GC Aesthetics was founded in 2007 and raised its 1st funding round 2 years after it was founded.
GC Aesthetics is headquartered in Dublin, Ireland.
Carlos Reis Pinto is the current CEO of GC Aesthetics.
GC Aesthetics is a funded company, having raised a total of $232.81M across 8 funding rounds to date.
GC Aesthetics is involved in the development and distribution of breast implants for aesthetic and reconstructive surgeries. The company operates within the healthcare sector, focusing on medical devices. Solutions such as GCA Breast Implants and Nagor Implants are offered to enhance patient confidence and body image. Additionally, comprehensive warranty programs like GCA Comfort Plus are provided to ensure patient satisfaction and safety.
GC Aesthetics's top competitors include Establishment Labs, Sientra and BioAesthetics.
GC Aesthetics offers GCA Breast Implants, Nagor Implants, and GCA Comfort Plus Warranty.
GC Aesthetics has 17 investors. Key investors include Hayfin, Orbimed, Montreux Equity Partners, Barry's Tea, and bill mccabe.
The valuation of GC Aesthetics is $111.4M as of Aug 2017.